NEXTCURE INC's ticker is NXTC and the CUSIP is 65343E108. A total of 53 filers reported holding NEXTCURE INC in Q2 2022. The put-call ratio across all filers is 0.34 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1 | -99.8% | 1 | -99.7% | 0.00% | – |
| Q2 2023 | $542 | -99.7% | 301 | -99.7% | 0.00% | – |
| Q1 2023 | $175,143 | +309.2% | 118,340 | +289.8% | 0.00% | – |
| Q4 2022 | $42,806 | -63.4% | 30,359 | -28.4% | 0.00% | – |
| Q3 2022 | $117,000 | -45.1% | 42,411 | -6.5% | 0.00% | – |
| Q2 2022 | $213,000 | -37.7% | 45,357 | -35.6% | 0.00% | – |
| Q1 2022 | $342,000 | -21.9% | 70,440 | -3.4% | 0.00% | – |
| Q4 2021 | $438,000 | -58.2% | 72,900 | -53.1% | 0.00% | – |
| Q3 2021 | $1,048,000 | -77.4% | 155,492 | -73.0% | 0.00% | -100.0% |
| Q2 2021 | $4,629,000 | -52.7% | 576,445 | -41.1% | 0.00% | 0.0% |
| Q1 2021 | $9,792,000 | -58.8% | 978,240 | -55.2% | 0.00% | -75.0% |
| Q4 2020 | $23,780,000 | +153.0% | 2,181,618 | +104.2% | 0.00% | +100.0% |
| Q3 2020 | $9,401,000 | +32.3% | 1,068,398 | +222.2% | 0.00% | 0.0% |
| Q2 2020 | $7,108,000 | +2456.8% | 331,560 | +4323.2% | 0.00% | – |
| Q1 2020 | $278,000 | -80.7% | 7,496 | -70.7% | 0.00% | – |
| Q4 2019 | $1,440,000 | +331.1% | 25,562 | +136.0% | 0.00% | – |
| Q3 2019 | $334,000 | +230.7% | 10,831 | +60.0% | 0.00% | – |
| Q2 2019 | $101,000 | – | 6,769 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 721,302 | $4,862,000 | 2.75% |
| Sofinnova Investments, Inc. | 2,671,856 | $18,008,000 | 1.07% |
| Canaan Partners X LLC | 321,647 | $2,168,000 | 0.62% |
| TANG CAPITAL MANAGEMENT LLC | 300,000 | $2,022,000 | 0.42% |
| Diametric Capital, LP | 76,162 | $513,000 | 0.40% |
| Lion Point Capital, LP | 300,000 | $2,022,000 | 0.38% |
| DAFNA Capital Management LLC | 183,491 | $1,237,000 | 0.33% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 217,139 | $1,464,000 | 0.25% |
| Ikarian Capital, LLC | 509,155 | $3,431,000 | 0.24% |
| Orbimed Advisors | 2,711,013 | $18,272,000 | 0.20% |